LOGO-01.png
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
28 mars 2023 02h08 HE | Burning Rock Biotech Limited
GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
avicorelogo.png
Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
23 mars 2023 10h46 HE | Avricore Health Inc.
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching...
LOGO-01.png
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
07 mars 2023 03h38 HE | Burning Rock Biotech Limited
GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Announces Enrollment of Cerebral Amyloid Angiopathy Participants in Phase 1/2a Retinal Tracer Trial
21 févr. 2023 05h00 HE | Amydis, Inc.
SAN DIEGO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease biomarkers in the eye, today...
LOGO-01.png
Burning Rock provides an update on 2022 revenue guidance
17 janv. 2023 20h37 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
03 janv. 2023 09h25 HE | Burning Rock Biotech Limited
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...
LOGO-01.png
Burning Rock Reports Third Quarter 2022 Financial Results
15 nov. 2022 21h20 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Awarded Third Grant From The Michael J. Fox Foundation To Support First-In-Human Study of a Retinal Tracer for Parkinson’s Disease
27 oct. 2022 07h00 HE | Amydis, Inc.
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of diagnostic drug candidates targeting molecular biomarkers in the eye, today...
LOGO-01.png
Burning Rock Reports Second Quarter 2022 Financial Results
31 août 2022 05h29 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
avicorelogo.png
Avricore Health Reports Second-Quarter 2022 Results
29 août 2022 08h30 HE | Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. ...